BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,908,363 | -4.0% | 396,423 | +20.8% | 0.00% | 0.0% |
Q2 2023 | $20,736,047 | +11.6% | 328,102 | -20.6% | 0.00% | 0.0% |
Q1 2023 | $18,581,907 | +26.2% | 413,023 | +22.9% | 0.00% | 0.0% |
Q4 2022 | $14,723,711 | -19.6% | 336,081 | +21.0% | 0.00% | 0.0% |
Q3 2022 | $18,308,000 | -9.6% | 277,854 | -30.7% | 0.00% | 0.0% |
Q2 2022 | $20,261,000 | -13.6% | 401,094 | +9.3% | 0.00% | 0.0% |
Q1 2022 | $23,450,000 | -23.3% | 367,091 | +28.5% | 0.00% | -33.3% |
Q4 2021 | $30,590,000 | +13.9% | 285,590 | +9.4% | 0.00% | 0.0% |
Q3 2021 | $26,848,000 | +18.0% | 261,142 | +1.0% | 0.00% | +50.0% |
Q2 2021 | $22,744,000 | -3.1% | 258,557 | +7.2% | 0.00% | -33.3% |
Q1 2021 | $23,460,000 | +6.3% | 241,279 | +22.6% | 0.00% | 0.0% |
Q4 2020 | $22,065,000 | +1.3% | 196,743 | -16.2% | 0.00% | 0.0% |
Q3 2020 | $21,775,000 | +85.1% | 234,883 | +55.7% | 0.00% | +50.0% |
Q2 2020 | $11,767,000 | +128.1% | 150,871 | +71.1% | 0.00% | +100.0% |
Q1 2020 | $5,158,000 | -16.3% | 88,196 | +14.6% | 0.00% | 0.0% |
Q4 2019 | $6,165,000 | -74.5% | 76,955 | -76.6% | 0.00% | -75.0% |
Q3 2019 | $24,200,000 | +127.0% | 329,379 | +191.5% | 0.00% | +100.0% |
Q2 2019 | $10,660,000 | +3.4% | 113,013 | -12.2% | 0.00% | +100.0% |
Q1 2019 | $10,307,000 | +107.4% | 128,774 | +39.7% | 0.00% | 0.0% |
Q4 2018 | $4,969,000 | -53.4% | 92,173 | -32.5% | 0.00% | 0.0% |
Q3 2018 | $10,658,000 | +20.1% | 136,534 | -2.3% | 0.00% | 0.0% |
Q2 2018 | $8,871,000 | +61.3% | 139,721 | +133.0% | 0.00% | – |
Q1 2018 | $5,499,000 | +71.3% | 59,971 | +40.8% | 0.00% | – |
Q4 2017 | $3,211,000 | +256.8% | 42,592 | +229.6% | 0.00% | – |
Q3 2017 | $900,000 | +209.3% | 12,924 | +125.2% | 0.00% | – |
Q2 2017 | $291,000 | -10.2% | 5,739 | -29.1% | 0.00% | – |
Q1 2017 | $324,000 | +194.5% | 8,090 | +105.0% | 0.00% | – |
Q4 2016 | $110,000 | +205.6% | 3,946 | +222.1% | 0.00% | – |
Q3 2016 | $36,000 | -23.4% | 1,225 | -47.4% | 0.00% | – |
Q2 2016 | $47,000 | +193.8% | 2,331 | +165.5% | 0.00% | – |
Q1 2016 | $16,000 | -95.2% | 878 | -93.1% | 0.00% | – |
Q4 2015 | $335,000 | +116.1% | 12,705 | +74.4% | 0.00% | – |
Q3 2015 | $155,000 | +2114.3% | 7,284 | +2712.4% | 0.00% | – |
Q2 2015 | $7,000 | – | 259 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |